These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36746676)

  • 1. Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells.
    Alamón C; Dávila B; Cerecetto H; Couto M
    Chem Biol Drug Des; 2023 Jun; 101(6):1435-1445. PubMed ID: 36746676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines.
    Giannopoulou E; Dimitropoulos K; Argyriou AA; Koutras AK; Dimitrakopoulos F; Kalofonos HP
    Invest New Drugs; 2010 Oct; 28(5):554-60. PubMed ID: 19603143
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Couto M; Alamón C; García MF; Kovacs M; Trias E; Nievas S; Pozzi E; Curotto P; Thorp S; Dagrosa MA; Teixidor F; Viñas C; Cerecetto H
    Cells; 2020 Jun; 9(6):. PubMed ID: 32517054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp.
    Kim JY; Kim HS; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3785-3793. PubMed ID: 31262905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death.
    Eimer S; Belaud-Rotureau MA; Airiau K; Jeanneteau M; Laharanne E; Véron N; Vital A; Loiseau H; Merlio JP; Belloc F
    Cancer Biol Ther; 2011 Jun; 11(12):1017-27. PubMed ID: 21508666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells.
    Tam S; Al-Zubaidi Y; Rahman MK; Bourget K; Zhou F; Murray M
    Pharmacol Rep; 2022 Oct; 74(5):998-1010. PubMed ID: 35908023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity.
    Gaelzer MM; Coelho BP; de Quadros AH; Hoppe JB; Terra SR; Guerra MC; Usach V; Guma FC; Gonçalves CA; Setton-Avruj P; Battastini AM; Salbego CG
    PLoS One; 2016; 11(4):e0154612. PubMed ID: 27123999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma.
    Omoruyi SI; Ekpo OE; Semenya DM; Jardine A; Prince S
    Apoptosis; 2020 Apr; 25(3-4):261-274. PubMed ID: 32036474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of taraxerol acetate in human glioblastoma cells and a mouse xenograft model via induction of autophagy and apoptotic cell death, cell cycle arrest and inhibition of cell migration.
    Hong JF; Song YF; Liu Z; Zheng ZC; Chen HJ; Wang SS
    Mol Med Rep; 2016 Jun; 13(6):4541-8. PubMed ID: 27081915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib.
    Bagherian A; Roudi B; Masoudian N; Mirzaei H
    Food Funct; 2021 Nov; 12(21):10926-10937. PubMed ID: 34647945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation.
    Mele L; la Noce M; Paino F; Regad T; Wagner S; Liccardo D; Papaccio G; Lombardi A; Caraglia M; Tirino V; Desiderio V; Papaccio F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):160. PubMed ID: 30987650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaurene diterpene induces apoptosis in U87 human malignant glioblastoma cells by suppression of anti-apoptotic signals and activation of cysteine proteases.
    Lizarte Neto FS; Tirapelli DP; Ambrosio SR; Tirapelli CR; Oliveira FM; Novais PC; Peria FM; Oliveira HF; Carlotti Junior CG; Tirapelli LF
    Braz J Med Biol Res; 2013 Jan; 46(1):71-78. PubMed ID: 23314342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
    Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
    Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis.
    Bittencourt LFF; Negreiros-Lima GL; Sousa LP; Silva AG; Souza IBS; Ribeiro RIMA; Dutra MF; Silva RF; Dias ACF; Soriani FM; Martins WK; Barcelos LS
    J Neurooncol; 2019 Sep; 144(3):463-473. PubMed ID: 31392596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction.
    Dai CH; Shu Y; Chen P; Wu JN; Zhu LH; Yuan RX; Long WG; Zhu YM; Li J
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3786-3798. PubMed ID: 30315932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells.
    Zappavigna S; Scuotto M; Cossu AM; Ingrosso D; De Rosa M; Schiraldi C; Filosa R; Caraglia M
    J Exp Clin Cancer Res; 2016 Oct; 35(1):167. PubMed ID: 27770821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS-mutated non-small cell lung cancer cells are responsive to either co-treatment with erlotinib or gefitinib and histone deacetylase inhibitors or single treatment with lapatinib.
    Kurtze I; Sonnemann J; Beck JF
    Oncol Rep; 2011 Apr; 25(4):1021-9. PubMed ID: 21271222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels.
    Villalpando-Rodriguez GE; Blankstein AR; Konzelman C; Gibson SB
    Oxid Med Cell Longev; 2019; 2019():9561281. PubMed ID: 31636810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.